A phase IIa study to evaluate safety and efficacy of Rezivertinib(BPI-7711) in locally advanced or metastatic/recurrent treatment-naive NSCLC patients with EGFR mutation
Rezivertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase IIa study to evaluate safety and efficacy of Rezivertinib(BPI-7711) in locally advanced or metastatic/recurrent treatment-naive NSCLC patients with EGFR mutation ### Output: Rezivertinib